Clinical Read2026-06-11

Revumenib with venetoclax and decitabine/cedazuridine - (SAVE)

Syndax Pharmaceuticals Inc.SNDX
Indication
R/R or newly diagnosed AML
Stage
phase1
Event
Phase 1/2